Jia Zhou

View Scopus Profile

Emailjizhouutmbedu

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Research Strategic Pillar Keywords

Infectious/ Immunological Health
Life Span Health
Metabolic Health

Fingerprint

Dive into the research topics where Jia Zhou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

20 Active
37 Completed

Zhou, Jia
Zhou, J.
9/1/22 → 8/31/24
Project: Other project
Zhou, Jia
Zhou, J.
9/1/22 → 8/31/24
Project: Other project
5-HT2 Receptor Allosterism in Cocaine Use Disorder
Zhou, J.
8/1/22 → 4/30/27
Project: Other project
5-HT2 Receptor Allosterism in Cocaine Use Disorder
Zhou, J.
8/1/22 → 4/30/27
Project: Other project
Dr. Zhou, Jia
Zhou, J.
4/1/22 → 3/31/24
Project: Other project

174 Article
27 Review article
6 Editorial
3 Chapter
More

Allosteric inhibitors of the main protease of SARS-CoV-2
Samrat, S. K., Xu, J., Xie, X., Gianti, E., Chen, H., Zou, J., Pattis, J. G., Elokely, K., Lee, H., Li, Z., Klein, M. L., Shi, P. Y., Zhou, J. & Li, H., Sep 2022, In: Antiviral research. 205, 105381.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Antiviral Agents against Flavivirus Protease: Prospect and Future Direction
Samrat, S. K., Xu, J., Li, Z., Zhou, J. & Li, H., Mar 2022, In: Pathogens. 11, 3, 293.
Research output: Contribution to journal › Review article › peer-review

Open Access
3 Scopus citations
Heterocyclic G protein-coupled receptor 52 (GPR52) agonists
Zhou, J., Allen, J., Wang, P. & Felsing, D., Apr 14 2022, IPC No. Nonprovisional application 63/090,519
Research output: Patent
Highlights on Most Cited Publications 2019-2020
Zhou, J., Aug 2022, In: Current topics in medicinal chemistry. 22, 21, p. 1729-1730 2 p.
Research output: Contribution to journal › Editorial › peer-review
Induction of Genes Implicated in Stress Response and Autophagy by a Novel Quinolin-8-yl-nicotinamide QN523 in Pancreatic Cancer
Kuang, Y., Ye, N., Kyani, A., Ljungman, M., Paulsen, M., Chen, H., Zhou, M., Wild, C., Chen, H., Zhou, J. & Neamati, N., Apr 28 2022, In: Journal of medicinal chemistry. 65, 8, p. 6133-6156 24 p.
Research output: Contribution to journal › Article › peer-review

US Patent Issued to The Board of Regents of The University of Texas System on April 28 for "EPAC1 activators as HIV latency reversal agents (LRA)" (Texas Inventors)
Jia Zhou
4/29/20
1 item of Media coverage
Press/Media: Expert Comment

Jia Zhou, PhD, MS

Personal profile

Research Strategic Pillar Keywords

Fingerprint

Network

Dive into details

Zhou, Jia

Zhou, Jia

5-HT2 Receptor Allosterism in Cocaine Use Disorder

5-HT2 Receptor Allosterism in Cocaine Use Disorder

Dr. Zhou, Jia

Allosteric inhibitors of the main protease of SARS-CoV-2

Antiviral Agents against Flavivirus Protease: Prospect and Future Direction

Heterocyclic G protein-coupled receptor 52 (GPR52) agonists

Highlights on Most Cited Publications 2019-2020

Induction of Genes Implicated in Stress Response and Autophagy by a Novel Quinolin-8-yl-nicotinamide QN523 in Pancreatic Cancer

US Patent Issued to The Board of Regents of The University of Texas System on April 28 for "EPAC1 activators as HIV latency reversal agents (LRA)" (Texas Inventors)

Jia Zhou, PhD, MS

Personal profile

Research Strategic Pillar Keywords

Fingerprint

Network

Projects

Research output

Press / Media